CHRISTINA ROLAND: Open Payments
NPI 1477102119 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 49 payments from 13 companies in 2025. Trend: 2023 $2,585 · 2024 $1,579 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 10 | $226 |
| Amgen Inc. | 12 | $193 |
| UCB, Inc. | 6 | $120 |
| Mallinckrodt Hospital Products Inc. | 4 | $100 |
| ABBVIE INC. | 5 | $97 |
| Novo Nordisk Inc | 3 | $55 |
| PFIZER INC. | 2 | $51 |
| Lilly USA, LLC | 2 | $34 |
| Almatica Pharma LLC | 1 | $24 |
| Organon LLC | 1 | $21 |
Products named: BRIUMVI, Bimzelx, OTEZLA, ACTHAR, ENBREL, XELJANZ, RINVOQ, Rybelsus.
Industry payments across AR — which companies pay providers there.
